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Acute oliguric interstitial nephritis
PRINCIPAL DISCUSSANT: CHARLES VAN YPERSELE DE STRIHOU
Université Catholique de Louvain and Cliniques Universitaires St-Luc, Bruxelles, Belgique
Case presentation
A 58-year-old woman was admitted to the Cliniques Universi-
tajres St-Luc for fever of 4 days duration. The patient, a labora-
tory technician in a medical research unit, uses methyl-
cholanthrene at regular intervals and without gloves handles rats
as part of her duties. She had been bitten by rats on several occa-
sions, most recently 8 days earlier. Seven days prior to admis-
sion while on holiday in France, the patient ate a spoiled pate.
Six days prior to admission, she became anorectic. Three days
prior to admission, she noticed herpetic vesicles on her lips. On
the same day, she also developed acute right lumbar pain and her
temperature rose to 38.7° C. She treated herself with one tablet
of cotrimoxazole. During the next 2 days, her temperature re-
mained between 39.5° and 40.4° C despite the continued use of
cotrimoxazole and acetylsalicylic acid. Because of persistent fe-
ver and right lumbar pain, the patient returned to Belgium and
was admitted the following evening.
The physical examination revealed the following data: temper-
ature, 39.5° C; pulse, 100 beats/mm; blood pressure (supine),
110/80 mm Hg; chest, no rales; cardiac auscultation, Grade 1/VI
early systolic murmur; the tip of the spleen was palpated as well
as the lower pole of the right kidney; the liver was not increased
in size; the remainder of the examination was unremarkable.
Laboratory findings revealed the following: blood urea, 43 mg;
serum creatinine, 1.4 mg/dl; serum sodium, 131 mEq; serum po-
tassium, 3.6 mEq; total carbon dioxide content, 23 mEq/liter;
hemoglobin, 15.6 g/dl; white blood cell (WBC) count, 52001mm3;
serum lactate dehydrogenase (LDH), 619 U (normal, 140 to 300
U); creatinine phosphokinase (CPK), 31.5 U (normal, 3 to 65 U);
serum glutamic oxaloacetic transaminase (SOOT), 36 U (normal,
6 to 30 U); serum glutamic pyruvic transaminase (SGPT), 16 U/
liter (normal, 4 to 40 U/liter); serum bilirubin, 0.5 mgldl. Results
of urinalysis revealed the following: specific gravity, 1.015; pH,
5; no proteinuria, glucosuria, or sediment abnormalities, Several
blood cultures and urine cultures, obtained during the first 24
hours, were sterile. ASLO titers were within normal limits. Paul-
Bunnell, Widal and Wright reactions were negative. Serologic
studies for the following agents were within normal limits or neg-
ative: 16 different serotypes of leptospirosis, toxoplasma, in-
fluenza A and B, parainfluenza I, II, and III, adenovirus, Q fe-
ver, Eaton Agent, Coxsackie B1 through B5, herpes, cyto-
megalovirus, EB virus, and hepatitis B.
During the first two hospital days, right lumbar and abdominal
pain persisted and the patient vomited once. She was treated
with acetylsalicylic acid administered intravenously, but she re-
mained febrile. Several blood cultures obtained were sterile. In
the evening of the second hospital day, her temperature fell to
37.8° C and remained below 370 C throughout the rest of her hos-
pital course. The patient continued to be anorectic and vomited
several times; persistent right lumbar and abdominal pain re-
quired the administration of pentazosin (Fortal®). Twelve hours
after admission, a second urinalysis disclosed slight proteinuria
(0.2 glliter), 2 to 4 WBC per high power field (HPF), and a few
hyaline and granular casts. Urine culture was sterile. During the
first 24 hours, urine volume was 1050 ml. The urine contained:
sodium, 3 mEq; urea, 13.3 g; and creatinine, 1185 mg/liter. On
the morning of the third hospital day, blood analysis revealed:
urea, 113 mg; creatinine, 3.6 mg; hemoglobin, 17 g/dl; WBC
count, 14,100 mm3 with 83% neutrophils and no eosinophils. A
morning urine sample contained: protein, 19 g; glucose, 0.4 g/
liter; 1 to 3 WBC and 10 to 15 red blood cells (RBC)/HPF. The
24-hour urine volume at that time was only 180 ml and it con-
tained: sodium, 89 mEq; urea, 2.75 g; and creatinine, 485 mg/
liter; 24-hour urine protein excretion was 1.9 g. The patient ap-
peared to be slightly dehydrated, and 4 liters of saline were ad-
ministered. On the fourth day, however, the patient remained
oliguric (24-hour urine volume, 110 ml). Blood urea concentra-
tion increased to 180 mg, and serum creatinine concentration in-
creased to 6.1 mg/dl. Echography revealed kidneys of normal
size without evidence of obstruction.
Six days after admission, anuria persisted; blood urea concen-
tration was 228 mg, and serum creatinine concentration was 8.8
mg/dl. Intravenous urography revealed a slight but persistent
nephrogram and a normal pelvicalyceal system visible on late
films. A percutaneous renal biopsy was obtained immediately
thereafter, and the results will be described later. One week after
admission, IgA and 1gM levels were elevated at 165 and 321%,
respectively. IgE and IgO levels were normal. Serum corn-
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plement was at the lower limit of normal. Ten days later, the
same observations were made but in addition IgG levels had in-
creased to 138%. No specific treatment was given. Two weeks
after admission, the urine volume exceeded 400 mllday for the
first time and increased to normal levels thereafter. The patient
underwent hemodialysis three times in the interim. Results of
urinalysis 12 days after admission revealed protein content of 5 g/
liter, 50 WBC/HPF, and 10 RBC/HPF. Sixteen days after admis-
sion, the 24-hour urine volume exceeded I liter, and protein and
sediment abnormalities disappeared from the urine. Twenty days
after admission, serum creatinine concentration was 1 mg and
blood urea concentration was 33 mgldl. Results of urinalysis
were normal.
Discussion
DR. CHARLES VAN YPERSELE DE STRIHOU (Pro-
fessor of Medicine, Head, Renal Service, University
of Louvain Medical School, Cliniques Universi-
taires St-Luc, Louvain en Woluwe, Brussels): I
should like first to discuss the patient's presentation
and the initial physical and laboratory findings. In
brief, she suffered for 4 days prior to admission
from intense right lumbar pain and elevated temper-
ature, while not responding to cotrimoxazole thera-
py. Although deterioration of her general condition
was the immediate problem on admission, renal fail-
ure soon appeared and progressed to oliguria and
anuria. On admission, the patient appeared to be
slightly dehydrated. Urinary sediment was normal
and the urinary concentration of sodium was low,
whereas the urinary concentrations of urea and
creatinine were elevated. Infusion of several liters
of saline, however, failed to restore renal function.
Dehydration can thus be eliminated as the sole
cause of renal failure. Urinary tract obstruction,
suggested by the right lumbar pain and the lack of
urinary sediment abnormalities, can be ruled out as
well because neither echographic examination nor
i.v. urography demonstrated any evidence for ob-
struction.
The diagnostic process thus inevitably leads to
primary renal disease as the cause of the severe oh-
guria in this patient. Acute or subacute glomerulo-
nephritis is unlikely because she did not initially
have hypertension, edema, proteinuria, or any uri-
nary sediment abnormalities, in particular hema-
tuna and red cell casts. It is noteworthy, however,
that 3 days after admission, a second urinalysis dis-
closed a high protein content and red blood cells,
but not red blood cell casts. Acute ascending pyelo-
nephritis is also unlikely because (1) the patient did
not have chills or pyuria, (2) her temperature re-
mained constant after the second hospital day, and
(3) urine cultures were sterile. The findings of the
urine cultures, however, should be interpreted cau-
tiously because the patient received cotrimoxazole
prior to admission.
The sudden onset of oligoanuric renal failure in a
patient with symmetric, slightly enlarged kidneys
certainly suggests acute tubular necrosis (ATN);
the dense, persisting nephrogram observed on i.v.
urography also supports this diagnosis, although in
one series of 20 patients both signs were absent in
20% of the patients [1]. Several features, in this pa-
tient, however, are not common in ATN. A causal
factor could not be identified: despite a detailed his-
tory, no toxic factors were discovered, and al-
though an increase in temperature was seen early in
her course, there was no evidence for septic shock.
Slight lumbar pain may be present in ATN, but in-
tense pain, which required potent analgesics in this
patient, is not a usual finding. Lumbar pain is seen
rarely, however, in toxic nephropathies such as that
induced by carbon tetrachloride inhalation. Serum
analysis failed to disclose any sign of hepatic dys-
function, rhabdomyolysis, or intravascular hemoly-
sis. Finally, chemical analysis of the urine argues
against a diagnosis of ATN on admission because
the urinary sodium concentration was low, and the
urine-to-plasma ratios for urea and creatinine were
high. In a recent prospective study, Miller et al ob-
served a urinary sodium concentration below 20
mEq/liter in less than 10% of the patients with non-
oliguric ATN [2]. Similarly, a urine-to-plasma ratio
for creatinine above 40 was observed in less than
10% of these patients. A combination of these two
indexes, the "renal failure index" [(urinary sodium,
mEq/liter)/(urine-to-plasma creatinine ratio)], was
below 1 in only 6% of the patients with nonoliguric
ATN, whereas in our patient this index reached 0.6.
Taken together, these observations lead us to sus-
pect another cause of acute renal failure, namely,
acute interstitial nephritis (AIN).
Acute interstitial nephritis is probably less rare
than is believed currently. In a recent series of 976
patients with acute renal failure, Richet et al per-
formed renal biopsy in 218 patients in whom the di-
agnosis was not clear-cut [3]. Pure AIN was ob-
served in 29 patients—that is, 14%. An almost iden-
tical proportion has been reported by Wilson [4].
Over the last few years, we have been more aggres-
sive in performing renal biopsy in acute renal failure
because the biopsy results provide clues not only to
AIN but also to other unsuspected glomerular or
vascular diseases. Richet argues that renal biopsy is
indicated in all patients with acute renal failure un-
der the following conditions: (1) when accompanied
by systemic manifestations such as a cutaneous
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rash, arthralgias, unexplained temperature, raised
level of blood eosinophils; (2) when the expected
diuresis does not occur within the usual time limits;
(3) when renal failure is subacute and associated
with atypical urinary features [3]. In his series of
biopsies, Richet reported only a few perirenal he-
matomas [5]. They were encountered only in vascu-
lar renal diseases and led to nephrectomy in three
patients. The frequency of this complication,
though low, justifies a cautious approach to renal
biopsy in acute renal failure and requires rigorous
control of the hemorrhagic tendency and hyper-
tension commonly associated with acute renal fail-
ure. Dr. Cosyns, would you report the findings of
the renal biopsy?
DR. J. P. COSYNS (Department of Pathology,
Cliniques Universitaires St-Luc, Louvain en Wo-
luwe, Brussels): The renal tissue obtained by needle
biopsy was composed of 25 glomeruli and a large
portion of medulla. Except for one hyalinized gb-
merulus, the glomeruli showed only minimal abnor-
malities—that is, a few polymorphonuclear neutro-
phils in some capillary lumina and some swelling of
the epithelial cells. The vessels were normal. There
was considerable congestion of the intertubular
capillaries with areas of interstitial hemorrhage and
there were nucleated cells in the vasa recta. There
was no interstitial fibrosis. There was, however, dif-
fuse interstitial edema and cellular infiltration pre-
dominantly in a large subcapsular area, in the
boundary zone nd in the medulla (Fig. I). The infil-
trating cells were mainly lymphocytes, mononucle-
ar cells, a few plasma cells, and rare polymorphonu-
clear neutrophils. There were no eosinophils. The
tubular architecture was normal except for spotty
tubular loss without atrophy and some dilatation in
the cortex. Some epithelial linings were flattened
and showed increased cytoplasmic acidophilia and
nuclear density. These findings were obvious in the
upper medulla, in the midportion of the cortex
where a few mitoses were seen, and in the severely
infiltrated subcapsular area where there was some
tubular loss and rare atrophic tubules. In this area,
the staining of the tubular basement membranes by
PAS and PASM was very weak (Fig. 2). No overt
rupture was seen. The inflammatory cells were in
close relation with the altered basement mem-
branes. A few inflammatory cells were visible be-
tween tubular epithelial cells but not in the tubular
lumen. Rare eosinophilic proteinaceous casts but
no granular or pigmented casts were seen. Finally,
rare crystalline deposits resembling calcium oxalate
were present in the lumen of cortical tubules. Direct
immunofluorescent staining failed to reveal IgG,
IgA, IgE, fibrinogen or the third component of com-
plement (C3). A few plasma cells fixed the anti-IgM
antiserum. The electron microscopic examination
revealed a normal glomerulus, interstitial edema,
and well-differentiated tubules.
The microscopic study allows us to exclude gb-
merular or vascular disease. We are dealing either
with ATN or AIN. This differential diagnosis is not
always easy for the pathologist since shock-induced
ATN with a prominent cellular interstitial reaction
and AIN may be histologically similar [6]. Ooi et al
[7] have described a tubular lesion named "tubu-
litis" defined as the infiltration of acute or chronic
inflammatory cells, or both, in the peritubular re-
gions or between the lining epithelial cells, with or
without disruption of the tubular basement mem-
brane. This lesion is not specific to AIN since it has
also been observed by the same group in a patient
with ATN following abortion. Furthermore, agents
such as cephalothin [6, 8] or gentamicin [9] may
produce either ATN or AIN. It is noteworthy that
the lesions observed as a consequence of adverse
reaction to certain drugs such as glafenin have been
termed acute tubulo-interstitial lesions [10]. These
lesions seem to be representative of an "inter-
mediate phase" between ATN, following an epi-
sode of shock, and AIN. In light of current data,
observers are questioning whether these lesions
should be classified as ATN with prominent inter-
stitial cellular infiltration, or more properly as true
AIN [3]. Nevertheless, in view of the clear findings
of interstitial cellular infiltration, particularly in the
important subcapsular area, I believe this patient
has AIN. We should remain cognizant, however,
both of the lack of well-defined histopathobogic cri-
teria in AIN and of the small sample of renal tissue
obtained by needle biopsy, which is not necessarily
representative of the whole renal parenchyma [11].
DR. C. VAN YPERSELE: We and Dr. Cosyns thus
conclude that this patient has AIN. I should like to
comment further on a few unusual aspects of this
patient's course, and then proceed to a discussion
of the possible cause of AIN in this patient.
Intense lumbar pain has been reported in several
patients with AIN [12—15]. It is probably due to the
distention of the renal capsule by interstitial edema,
evidenced sometimes by an increase in renal size
[16, 17]. Interestingly, in two patients with antibiot-
ic-induced interstitial nephritis [16, 18] the lumbar
pain was unilateral, as it was in our patient. A dense
immediate nephrogram has also been observed in
another patient with antibiotic-induced interstitial
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Fig. 1. Subcapsular area with considerable degree of interstitial edema and cellular infiltration. There is some tubular loss but no
glomerular abnormalities (Trichrome x390).
nephritis [19]. These cases viewed together suggest
that i.v. urography does not help in distinguishing
between ATN and AIN.
The "prerenal" characteristics of the urine ob-
served at the onset of renal failure in our patient
continue to be puzzling. Indeed, the limited data
available suggest that the results of chemical urine
analysis in AIN are identical with those seen in
ATN. It is possible however that at its earliest stage
AIN behaves differently. In acute ureteral obstruc-
tion, it has been demonstrated that the urine sodium
concentration decreases, whereas the concentrating
power of the kidney is preserved [20]. Two patients
with obstructive renal failure in whom the sodium
concentration was initially low have been observed
[21]. It is thus possible that the results in our patient
indicate an incipient intrarenal obstruction. What-
ever the interpretation, it should be remembered
that when the patient became oliguric, the results of
urine chemistries were compatible with ATN.
What are the possible causes of AIN in our pa-
tient? Acute interstitial nephritis is a very hetero-
genous condition but two major causes have been
identified: drugs and infection. Our patient had not
taken any drugs save acetylsalicylic acid and cotri-
moxazole. Acute interstitial nephritis has been attrib-
uted to sulfonamide toxicity [22], and cotrimoxa-
zole does contain a sulfonamide derivative. Fur-
ther, acute reversible deterioration of renal function
after administration of cotrimoxazole has been re-
ported in 20 patients [23, 24]; in 2 of those patients,
renal biopsy showed ATN with an interstitial reac-
tion [23]. Two instances of cotrimoxazole-induced
AIN have been reported; one patient had an in-
creased serum concentration of IgE, and another
patient had many eosinophils in the urine [18, 25].
In our patient, however, cotrimoxazole toxicity
does not seem to be the cause of the disease. In-
deed, the amount taken was much lower than that in
reported observations of acute renal failure from
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Fig. 2. Weakly-stained tubular basement membranes in the interstitial areas infiltrated by chronic inflammatory cells, chiefly by poly-
morphonuclear leukocytes (trichrome, x625). Insert shows inflammatory cells (arrow) infiltrating between the tubular epithelial cells
and the tubular basement membrane (trichrome, X 1560).
this agent. Furthermore, the symptoms of fever and
lumbar pain antedated intake of the drug.
The presence of an infection responsible for the
fever is suggested by the history, the elevated WBC
count, and the evolution of serum protein changes;
that is, the early increase of 1gM and IgA followed
10 days later by an increase in IgG concentration.
The fact that the serum complement concentration
remained at the lower limit of normal during this
inflammatory reaction suggests that complement
was consumed by circulating immune complexes.
The concentration of immune complexes, as mea-
sured by the Cambiaso method [26], was initially at
the upper limit of normal but fell subsequently.
These findings should be interpreted with caution as
the detection of immune complexes depends very
much on the technique used; results may be nega-
tive with some techniques and positive with others.
Although our observations are suggestive of an in-
fectious disease, we must acknowledge that no
causal agent could be identified. Blood and urine
cultures were consistently sterile, antistreptolysin
titers were normal, and the antibodies against a
multitude of microbial species were normal. The
spontaneous decrease in temperature suggests a vi-
ral infection. This hypothesis is further supported
by the striking occurrence of acute renal failure in
two additional patients, both working in the same
laboratory and manipulating rats, within the 3
months preceding this patient's illness. Similarities
can be seen among all three patients. Dr. Van-
denbroucke, would you present briefly the history
of these other two patients?
DR. J. M. VANDENBROUCKE (Physician, Renal
Service, Cliniques Universitaires St-Luc, Louvain
en Woluwe, Brussels): As Dr. van Ypersele men-
tioned, a few weeks prior to admission of the pa-
tient under discussion today, we observed an identi-
cal clinical picture in two people working in the
same laboratory as this patient. The first patient, a
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37-year-old man, works with rats and pigeons. He
suffered, a few days after his wife, with an in-
fluenza-like syndrome and was treated with phe-
nacetin and doxacycline. Three days later, he had
an episode of vomiting, and 2 days later, he had
chills and a temperature of 390 C. At that time, the
patient complained of heavy lumbar pain, pre-
dominantly on the right side, and urine volume de-
creased. His physician found proteinuria; the next
day, urinalysis disclosed the protein content to be
17 g/liter with moderate leukocyturia. Serum creati-
nine concentration reached 6.5 mg/dl and the pa-
tient was admitted to the hospital. Physical exam-
ination revealed hypertension (200/120 mm Hg) and
bilateral flank pain. Blood analysis disclosed an ac-
celerated erythrocyte sedimentation rate (E.S.R.)
and an increased concentration of fibrinogen:
creatinine concentration was 9.2 mg; blood urea
was 135 mg/dl; enzymes were normal; WBC count
was normal without eosinophils. Results of urinaly-
sis revealed: protein content, 0.4 glliter; sediment, 3
to 6 WBC/HPF, 2 to 4 RBC/HPF; urine culture,
sterile. An i.v. urogram showed kidneys of in-
creased size with parenchymatous edema; excre-
tion was symmetric but slight; there was no evi-
dence of obstruction. During the hospital course,
daily urine volume remained above 1.5 liters; there
was no fever, and renal function returned rapidly to
normal with no specific treatment.
Two weeks later, the second patient was referred
to us for treatment of acute renal failure with mas-
sive proteinuria. The clinical history was similar: in-
tense lumbar pain, predominantly on the right, at
the beginning; a few days later, development of fe-
ver and vomiting; and proteinuria accompanied by
hematuria. On admission, the patient was febrile,
normotensive without symptoms of hypervolemia,
but had hepatosplenomegaly and an enlarged,
tender right kidney. Laboratory examination re-
vealed: an accelerated E.S.R. and increased con-
centration of fibrinogen in the blood; serum creati-
nine, 3.4 mg; blood urea, 104 mg!dl; LDH, 764 U;
SGOT, 93 U; SGPT, 74 U. Hemogram was normal:
WBC count, 9200/mm3 with monocytosis (15%) but
with no eosinophils. Urinary protein was 7.3 g/liter
initially but rapidly decreased; microhematuria also
disappeared rapidly. During the first two hospital
days, the patient was oliguric; subsequently the dai-
ly urine volume increased, exceeding 1.5 liters, with
a simultaneous decrease in serum creatinine con-
centration to normal.
In neither of these two patients did we find an
etiologic factor for the acute renal failure: tox-
icologic research was negative, serology was nega-
tive for leptospirosis and toxoplasmosis. Only in the
first patient did we observe a rise in titer for the
Coxsackie B4 antibodies of questionable signifi-
cance—1/128 to 1/5 12 and later 1/128. Immunoglob-
ulin studies showed a transient increase in IgA con-
centration.
DR. C. VAN YPERSELE: The striking similarity in
the courses of these three patients indeed suggests
the presence of an infectious agent which to date we
have not been able to identify.
I should now like to turn to a more in-depth dis-
cussion of the pathogenesis of AIN. Heptinstall de-
fines AIN as an acute inflammatory lesion of the in-
terstitium occasionally associated with tubular le-
sions but without glomerular involvement [6]. This
pathologic picture is observed in a great variety of
clinical renal disturbances, ranging from simple pro-
teinuria with only slight alterations of the urinary
sediment to acute renal failure. It may have various
immunologic manifestations and may occur in a va-
riety of circumstances, which suggests that AIN is
the common endpoint of diverse diseases acting
through different mechanisms. To the restrictively
defined AIN of Heptinstall, one should add the
acute interstitial lesions that may accompany gb-
merular or vascular diseases. It is probable that
AIN, like gbomerulonephritis, will be divided into a
variety of subgroups in the future.
Experimental acute interstitial nephritis. I plan to
review the various clinical conditions associated
with AIN, but first I will summarize the experimen-
tal immunologic manipulations that may induce
AIN. Three different mechanisms have been identi-
fied: the first relies on immune complexes, the sec-
ond on antitubular membrane antibodies, and the
third on the induction of delayed hypersensitivity.
Two models of AIN demonstrate the first mecha-
nism: The repeated injection of homologous cyto-
plasmic tubular (HCT) antigens [27] or the repeated
administration of heterobogous bovine albumin
(HBA) [28] in the rabbit result in the development
of interstitial nephritis characterized by mono-
nuclear infiltration and tubular lesions. In the HCT
antigen model, the glomeruli are spared, whereas in
the HBA model they are involved. On immuno-
fluorescence, granular IgG and C3 deposits are seen
along the tubular membrane. In the HBA model de-
posits are also located along the gbomerular base-
ment membrane. The lesions in the HCT antigen
model result apparently from the in situ combina-
tion of cytoplasmic tubular antigens slowly dif-
fusing from tubular cells with circulating antibody
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brought by blood flow to the basal membrane. In
the HBA model, immune complexes of bovine albu-
min and antibovine albumin antibodies are carried
through the circulation into the glomeruli and along
the tubular basement membrane. From these mod-
els, we may conclude that immune complexes may
provoke acute interstitial reaction whether they are
formed within the interstitium or are located there
secondarily.
The second mechanism is demonstrated by ex-
periments in which purified rabbit tubular mem-
branes are injected into the guinea pig [29]. Acute
interstitial nephritis develops subsequently and is
characterized by cellular infiltration of plasmo-
cytes, mononuclear cells, macrophages, and giant
cells, which provoke tubular lesions. On immuno-
fluorescent examination, linear deposits of IgG and
C3 are observed along the tubular basement mem-
brane. This model of AIN is due to the development
of circulating antitubular basement membrane (anti-
TBM) antibodies, which have been identified in the
circulation. Furthermore, injection of guinea pig
serum induces the disease in nonimmunized recipi-
ents [30]. This reaction requires the activation of
complement, at least through the alternate pathway
[3 1—33], and probably also requires the presence of
intact bone marrow cells in the recipient [34]. When
the disease is transferred to a nonimmunized recipi-
ent, the injected antibody initiates the tubular le-
sion, but subsequently the recipient develops au-
toantibodies, thus amplifying the initial reaction
[35]. From this model, we conclude that anti-TBM
antibodies may provoke interstitial nephritis medi-
ated by complement activation and marrow cells,
which might suggest cellular immunization as well.
These anti-TBM antibodies may be generated either
by the injection of heterologous TBM or by the lib-
eration of autologous hidden tubular membrane an-
tigens.
The third mechanism relies on delayed hyper-
sensitivity. Guinea pigs or rats are injected with bo-
vine gamma globulin (BGG) at a rate appropriate to
stimulate delayed hypersensitivity [36]. Aggregated
BGG is then injected into the subcortical region of
the kidney. Immediately, there is an intense mono-
nuclear cell infiltration, which destroys the tubular
components. This type of interstitial reaction is cer-
tainly due to delayed hypersensitivity because it is
transferable by lymphocytes but not by the serum
of the donor. Furthermore, no circulating anti-BGG
antibodies are demonstrated and no immunoglobu-
lins are present in the kidney [37]. This model dem-
onstrates therefore that delayed hypersensitivity
may result in AIN if the stimulating antigen is lo-
cated within the kidney.
Clinical acute interstitial nephritis. How can
these mechanisms intervene in human disease? 1
will comment only briefly on the interstitial lesions
associated with glomerular diseases. Immune com-
plexes, probably DNA and anti-DNA, are observed
along the tubular basement membrane in more than
half the patients with lupus nephritis [38]. Other im-
mune complexes along the tubular basement mem-
brane have been reported in cryoglobulinemia [38]
and renal transplants [39, 40]. Linear anti-TBM
antibody deposits have been observed in rapidly
progressive glomerulonephritis with antiglomerular
basement membrane (anti-GBM) antibodies [38, 40]
and in renal transplants [41, 42]. These observations
illustrate the pathogenic role of humoral immunity
in the genesis of AIN. It is noteworthy that in renal
transplants the same immune challenge may result
in two different types of lesions. A detailed analysis
suggests that in addition to these two antibody-me-
diated lesions some cellular-mediated lesions—de-
layed hypersensitivity—are also involved.
In order to review AIN that is unaccompanied by
glomerular lesions, I will follow Richet's classifica-
tion [43]. This classification is based on the type of
cells infiltrating the kidney: polymorphonuclear or
mononuclear cells.
Acute interstitial nephritis with massive infil-
tration of polymorphonuclear cells and formation of
microabscesses is induced by septicemias, occa-
sionally of urinary origin. Urinary protein excretion
reaches 2 to 3 g/liter and is accompanied by pyuria.
Renal insufficiency is usually progressive, may be
severe, and is only slowly and partially reversible.
No immunoglobulins are seen in the kidney, and
circulating anti-TBM antibodies have not been de-
tected. Resolution of this type of AIN requires a
careful search for the cause of the septicemia and its
prompt treatment [44]. This variety of AIN was ob-
served in 6% of the 218 patients with acute renal
insufficiency biopsied by Richet [3].
Acute interstitial nephritis with mononuclear cell
infiltration is more heterogenous and may be pro-
voked either by drugs or infection. A drug may be
toxic by itself, as demonstrated by the dose de-
pendency of the lesions. This mechanism has been
invoked to account for the important interstitial le-
sions occasionally observed after administration of
polymyxin E, cephaloridine, cephalothin, and glafe-
nm [13, 17, 45—47]. Interestingly, the acute renal
failure provoked by these substances may be ac-
companied solely by minimal tubular lesions with-
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out cellular interstitial infiltration, a picture identi-
cal to that of ATN.
In other instances, drugs act apparently through
immune mechanisms: AIN is evoked by a normal
dose of the drug, sometimes simultaneously with
extrarenal manifestations of an immunologic con-
flict. The list of incriminated drugs is very long, but
the most frequently mentioned are: methicillin, phe-
nytoin, phenindione, rifampin, sulfonamides, and
less frequently, cephalothin, glafenin, and diuretics
(see Table 1) [8, 48]. The delay between the admin-
istration of the drug and the onset of renal lesions
varies from a few hours to several weeks.
The clinical picture is heterogenous. Frequently,
the onset of renal failure is acute and associated
with hematuria, which is sometimes macroscopic,
whereas a few series reveal consistent pyuria with a
large number of eosinophils. Occasionally, how-
ever, renal failure develops slowly without urinary
manifestations: the kidney may be increased in size
with associated severe lumbar pain, or in some pa-
tients, the kidneys may be normal in size or only
slightly enlarged. Renal failure is variable in severi-
ty and may require hemodialysis. Withdrawal of the
offending drug is usually accompanied by improve-
ment in renal function, providing further evidence
for a cause-and-effect relationship. Readministra-
tion of the drug can lead to another episode of renal
insufficiency [13, 48]. Total healing is frequent, but
occasionally persistent chronic renal failure has been
reported [8, 18, 49—51].
The existence of an immunologic conflict is sug-
gested by systemic clinical manifestations such as
fever, cutaneous rash, and arthralgias. These are by
no means always present. An increased number of
circulating eosinophils is often observed after ad-
Table 1. Prevalence of drug-induced acute interstitial nephritisa
Frequent Rare
Methicillin Oxacillin
Penicillin Nafcillin
Ampicillin Carbenicillin
Rifampin Cephalothin
Glafenin Tetracycline
Sulfonamides Thiazide
and cotrimoxazole Furosemide
Phenindione Phenylbutazone
Phenytoin Aminophenazone
PAS acid
Gold and bismuth salts
Azathioprine
Allopurinol
Phenobarbital
Cephalexin
a Data taken from Refs. 8 and 59.
ministration of methicillin [18, 52, 53] or diuretics
[48, 54, 55], in sporadic cases [56, 57], and rarely
after administration of drugs such as rifampin [8],
glafenin [13], or cephalothin [58]. On biopsy, lym-
phocytes, plasmocytes, and mononuclear cells are
present in abundance, often but not always accom-
panied by eosinophils. In a few patients, epithelioid
cell granulomas with giant cells were observed
[59-61]. The existence of a humoral immune reac-
tion is also suggested by the finding on renal biopsy
of linear IgO and occasionally of C3 deposits along
the tubular basement membrane. This has been re-
ported, however, only in a few instances of methi-
cillin-, penicillin-, or phenytoin-induced AIN [52,
53, 59, 62]. In these patients, circulating anti-TBM
antibodies were also demonstrated [52, 59, 62]. It
should be pointed out, however, that these abnor-
malities are exceptional: indeed, immunoglobulins
were absent in the renal biopsy of the six patients
with methicillin-induced AIN reported by Galpin
[18]. In a few patients with methicillin-induced AIN
and in one patient with cotrimoxazole-induced
AIN, increased serum concentrations of IgE were
observed [25, 63]. In a single patient with phenobar-
bitol-induced AIN, plasmocytes filled with IgE
were observed in the interstitium [64]. Usually,
however, all of these parameters are normal. Fur-
ther evidence for an antibody-mediated immune re-
action can be found in a positive Coombs reaction
in a few instances of ampicillin-, rifampin-, or glafe-
nm-induced AIN [8, 65, 66]. Lymphoblastic stimu-
lation or inhibition of leukocyte migration has been
occasionally reported in AIN due to methicillin, ri-
fampin, glafenin, phenytoin, and phenindione [13,
61, 62, 67, 68]. But, as mentioned earlier, the tests
are often negative. In summary, these data suggest
that the same drugs may evoke AIN through a vari-
ety of immune mechanisms, either humoral or cellu-
lar as well as produce toxic, dose-dependent renal
lesions.
The following hypothetical scheme might in-
tegrate the different pathogenic mechanisms de-
fined experimentally with the various immunologic
disturbances observed in clinical AIN. Interstitial
accumulation of the drug may result either from a
direct toxic effect of the drug on tubular cells with
subsequent diffusion through a ruptured tubular
basement membrane, or from its concentration
within peritubular capillaries, or from its combina-
tion with the tubular membrane acting as a hapten.
Once in the interstitium, the drug challenges immu-
nity and induces either humoral immunization or
cellular, delayed hypersensitivity immunization.
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Humoral reaction is either systemic, manifested in
the formation of circulating antibodies directed
against the drug or against the tubular membrane,
or local with infiltration of monocytes, lympho-
cytes, and plasmocytes. These latter cells are able
to synthesize immunoglobulins locally and form im-
mune complexes in situ. Delayed hypersensitivity
will bring about the invasion of the interstitium with
macrophage-stimulating lymphocytes. Within this
framework, it is conceivable that the same drug
elicits the same tubular lesions through different im-
mune mechanisms, the type of response being de-
termined by the genetically determined immune re-
sponsiveness of the patient, the degree of stimula-
tion of immunity, and the characteristics as well as
the quantity of the offending agent.
Whatever the mechanisms involved, it is quite
clear that it is extremely important, both in patients
with acute renal failure and in those with chronic
renal insufficiency who have an unexpected decline
in function, to look for evidence of activation of the
immune system and to suspect a deleterious role for
any drug recently taken by the patient. Detection of
increased amounts of eosinophils in the urine may
be helpful. If there is any doubt, renal biopsy should
be performed. Immunologic tests for the detection
of anti-TBM, IgE, Coombs reaction, inhibition of
lymphocyte migration, or lymphoblastic transfor-
mation are useful to support the hypothesis of drug-
induced interstitial nephritis. This critical attitude
allowed Lyons et al [48] to modify the apparently
inevitable degradation of renal function observed in
some patients with glomerulonephritis simply by in-
terrupting the administration of diuretics.
The role of infectious agents in the genesis of
AIN with mononuclear infiltration has been demon-
strated, although it is less extensively documented
than drug-induced AIN. The streptococcus has
been implicated in the context of a hyperergic reac-
tion that is sometimes associated with eosinophilia
[43, 69, 70] and is reminiscent of AIN following
scarlet fever, described more than a century ago
[71]. Leptospirosis may also produce AIN. Its
mechanism has been delineated in studies per-
formed in infected dogs [72]. The leptospires are ini-
tially found in the tubular lumen, but subsequently
their antigenic material is found in the interstitium,
either within macrophages or as discrete granular
deposits combined with antileptospire antibodies,
which are secreted locally by plasmocytes. An anal-
ogous lesion has been found in a lepromatous pa-
tient [43]: the Hansen bacilla or its antigenic com-
ponent has not been identified, but plasmocytes that
produce IgG have been found in the interstitium.
Toxoplasmosis [73], mononucleosis [74], and mea-
sles [4] have also been incriminated. No antibodies
have been identified in situ but the viral antigens
have been identified in the tubular cells. Virus-in-
duced AIN is well documented in animals. In the
fowl, infectious bronchitis virus is able to damage
tubular cells and induce a mononuclear infiltration
of the interstitium [75]. In the dog infected with ca-
nine adenovirus, the virus penetrates into tubular
cells and destroys them. Focal necrotic material is
then surrounded by lymphocytes, macrophages,
and plasmocytes that are filled with IgG anticanine
adenovirus antibodies [72]. Under those circum-
stances, however, anti-TBM antibodies have not
been demonstrated.
The same scheme as used earlier for drugs can
account for these observations: accumulation in the
interstitium of bacterial or viral antigens, which ar-
rive there either through tubular cells or by blood
flow; formation in situ of antibodies secreted by
plasmocytes; or arrival of delayed hypersensitivity
lymphocytes, creating a general inflammatory reac-
tion. Moreover, it has been demonstrated in a pa-
tient with leptospirosis that the infectious agent
may elicit further the formation of anti-TBM anti-
bodies, thus "amplifying" the initial renal lesion
[76]. In addition to AIN generated by drugs or infec-
tious agents, there are several reports in which it
has not been possible to indict either of these agents
because of the complexity of the situation [17, 77,
78].
At the end of this discussion of the causes of
AIN, I should reiterate that renal biopsies of many
patients with ATN do show conspicuous interstitial
infiltration. This occurrence is not unusual; of the
69 patients with ATN reported by Richet [43], 15
had slight interstitial lesions and 9 had severe ones.
These lesions have also been described by Kim-
melstiel [79], by Zollinger [80], and more recently
by Pasternack [81] in patients with ATN. The origin
of the infiltration has not been clearly defined: it
may represent residue of hematogenous bacterial
dissemination; it may be due to drug toxicity; or, as
we suggested earlier, it may be attributable to au-
toimmune reactions.
As already stated, the course of AIN is usually
favorable as soon as the offending drug is with-
drawn or the infectious agent destroyed. In a few
patients, however, the response was less favorable
and prednisone has been administered with some
success [16, 18, 48, 54, 77, 78]. Recently, Galpin
evaluated the effectiveness of steroids in methi-
cillin-induced AIN [18]. Of the eight patients who
were treated with prednisone, serum creatinine re-
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turned to control values in six patients, and stable
concentrations were obtained after an average of
only 9 days. In contrast, in the six patients who did
not receive prednisone, serum creatinine returned
to control values in only 2, and stable concentra-
tions were obtained only after 54 days. Although
these data suggest that prednisone may be effective
in MN, the incidence of residual renal functional
impairment in the control group was higher than
that reported elsewhere in the literature. In con-
clusion, I should like to point out that the more fre-
quent use of renal biopsy in acute renal failure may
be very helpful. This technique discloses unsus-
pected glomerular or vascular disease, allows the
identification of AIN as in the patient discussed
today, and should make it possible to institute ap-
propriate treatment more promptly.
Questions and Answers
DR. N. LAMEIRE (instructor in Medicine, Renal
Service, Akademisch Ziekenhuis, University of
Ghent): We discussed the first patient presented
today earlier in Ohent, and our tentative diagnosis
was salmonella food poisoning with dehydration
and possible ATN. That diagnosis was based on the
history of ingestion of the spoiled pate, the sple-
nomegaly, the absence of lymphocytosis, and the
pulse rate of only 100 beats/mm despite a temper-
ature of 400 C. Of course, now that the two other
cases from the same laboratory have been present-
ed, our original hypothesis must be dropped. None-
theless, I would return to your comments on the uri-
nary findings used to distinguish between ATN and
AIN. The first urine tests revealed a low concentra-
tion of sodium and a high concentration of urea.
During the first several days following admission,
she received no saline and she was vomiting. That
suggests to me that she had prerenal acute renal fail-
ure, which later evolved to ATN simply because of
dehydration.
DR. C. VAN YPERSELE: On admission renal fail-
ure was already present as evidenced by a serum
creatinine concentration of 1.9 mgldl, but there
were no clinical signs of dehydration and the patient
was not yet oliguric. Therefore, I do not think that
the patient initially had prerenal acute renal failure.
As to the subsequent progression of renal failure, I
have rarely seen prerenal failure from dehydration
evolve to ATN without associated severe signs of
hypovolemia, which this patient never had.
DR. P. MICHIELSEN (Professor of Medicine,
Head, Renal Service, University of Leuven Medical
School, Akademische Ziekenhuis, St-Rafael, Leu-
yen): With respect to Dr. Lameire's diagnosis in
this patient, you dismissed the hypothesis that she
had ATN secondary to dehydration. I believe we
should recall that this patient took aspirin in addi-
tion to cotrimoxazole prior to admission, and that
she received I g of acetylsalicylic acid intrave-
nously just before the episode of dehydration. The
recent work of Henrich suggests that prostaglandins
seem to balance the vasoconstrictive action of an-
giotension and renal nerves during hypovolemic or
hemorrhagic hypotension [82]. It could be argued
that the degree of dehydration seen in this patient,
which would not have evoked ATN, did so here be-
cause of the earlier treatment with acetylsalicylic
acid.
DR. C. VAN YPERSELE: That is an interesting
idea, but I believe that hypothesis must remain
speculative until sufficient data have been collected.
Furthermore, this hypothesis does not fit with the
interstitial infiltrate found on biopsy.
DR. P. MIcHIELsEN: There is a study by Torres in
which indomethacin has been shown to aggravate
glycerol-induced ATN in rabbits [83]. At one time,
we gave indomethacin to patients following trans-
plantation, but we had to discontinue this practice
because of the high incidence of ATN in this group
[84]. Thus, these observations support my hypothe-
sis.
DR. C. VAN YPERSELE: 1 think it is an alternative
possibility. As Dr. Lameire already pointed out, the
similar findings in the two other patients also argue
against that explanation.
DR. J. P. GODON (Agrégé, University of Liege):
To follow up the comments of Dr. Michielsen, we
observed a case of aspirin-induced AIN several
years ago in a woman who had absorbed 9 g of aspi-
rin.
DR. P. MICHIELSEN: The clinical evolution of the
two other patients was much more benign. They
had an acute febrile evolution followed by rapid re-
covery of renal function. They did not have the pro-
tracted anuria characteristic of the first patient's
course. She also had an i.v. urographic procedure
before the biopsy; do you know when that took
place?
DR. C. VAN YPERSELE: Yes, the i.v. urography
was performed in preparation for the biopsy, which
was done 2 hours after urography; the patient had
already been anuric for several days.
DR. P. MICHIELSEN: Are there any data that al-
low us to eliminate the iodine given on urography as
the cause of some of the interstitial infiltration? The
earliest report I know from the literature indicates
that definite ATN lesions can appear 1 day after the
procedure [85].
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DR. J. T. HARRINGTON: While I don't have any
systematic data regarding this issue, we have per-
formed many biopsies using fluoroscopy and I don't
believe we have seen an unanticipated degree of
interstitial infiltration or edema.
DR. N. LAMEIRE: Performing i.v. urography in a
dehydrated, anuric patient is certainly not without
danger, and for this reason we never use this proce-
dure preparatory to renal biopsy. Instead, we use
echography prior to biopsy, which gives a very
good visualization of the kidney even in a patient
with anuria.
DR. C. VAN YPERSELE: I should point out that the
patient was not dehydrated at the time of the
urographic procedure. Dehydration had been cor-
rected earlier.
DR. P. MICHIELSEN: Another question, if I may.
Which kidney did you biopsy?
DR. C. VAN YPERSELE: The right kidney was
biopsied.
DR. P. MICHIELSEN: I am somewhat puzzled by
the occurrence of intense pain on the right side in
this patient.
DR. C. VAN YPERSELE: As I mentioned earlier,
Hamburger, who has enormous experience in this
area, reports that diffuse lumbar pain in ATN may
be a bit more characteristic on the right side for rea-
sons that are not clear [86].
DR. N. LAMEIRE: If you suspect that the acute
episodes of the three patients presented today have
a similar etiology, you may have a slight clue to a
possible cause in the rise in the antibody titer
against Coxsackie virus in the second patient. As
you know, Coxsackie virus has been associated
with the lesions of glomerulonephritis, not inter-
stitial nephritis [87]. May I have your comments on
this possibility?
DR. C. VAN YPERSELE: First, our virologist be-
lieves that the small changes in the antibody titer
against Coxsackie virus noted in our patient should
not be viewed too rigorously. As I pointed out, I
think AIN is a very heterogeneous condition in
which most of the mechanisms that have been im-
plicated in the development of the several types of
glomerulonephritis are also involved. I quoted a re-
port of AIN following measles, and measles has al-
so been implicated in the development of glomeru-
lonephritis. Thus, I don't think there is an in-
compatibility—as a matter of fact, it makes things
more interesting.
DR. J. T. HARRINGTON: You mentioned earlier
Richet's indications for kidney biopsy and stated
that one was "prolonged" oliguria. What would you
consider to be prolonged oliguria—2 weeks, 3 weeks?
DR. C. VAN YPERSELE: In our department we are
slightly more conservative than Richet. I would
consider oliguria that lasts beyond 1 month to be a
prolonged episode.
DR. J. T. HARRINGTON: Earlier, you commented
on the difficulty in distinguishing between ATN and
AIN in the absence of a kidney biopsy. This is a
specific example of a more general problem, that of
making two different diagnoses affecting the same
organ system. We had similar difficulties with that
problem in the patients we described who had di-
uretic-induced interstitial nephritis [48]. All were pa-
tients who had known chronic glomerular disease
and in whom renal failure slowly progressed over a
matter of months. The major clue that superim-
posed disease was causing the renal failure was the
persistence of normal kidney size. That was the pri-
mary reason for repeating the kidney biopsies. Only
later, when we carefully perused the clinical rec-
ords systematically, did we realize that mild inter-
mittent eosinophilia and fleeting skin rashes had of-
ten occurred.
DR. G. RORIVE (Established Investigator, Fonds
National de Ia Recherche Scientfique, Head, Renal
Hypertension Unit, Hópital de Bavière, University
of Liege): I am somewhat surprised by the delay
between the first symptom and renal failure. In my
experience, the evolution of AIN is more rapid.
DR. C. VAN YPERSELE: The delay between drug
ingestion and the onset of renal failure is highly var-
iable—a few hours in the case of patients who have
probably been presensitized, several weeks in other
patients.
DR. G. R0RIVE: I agree that the delay between
drug absorption and the first symptoms varies con-
siderably among patients. Once the clinical signs
are present, however, the disease has an acute
course, and the reduction in renal function is maxi-
mal within a few hours or days. The evolution of
this patient was somewhat slower.
DR. C. VAN YPERSELE: The course of AIN is by
no means always as acute as you suggest; in diuret-
ic-induced AIN, for instance, the evolution ob-
served by Dr. Harrington in his patients [48] ex-
tended over a period of several months.
DR. G. R0RIVE: In five cases of glafenin-induced
AIN, I was struck by the rapidity of the evolution,
which lasted 3 or 4 days. One patient complained of
lumbar pain and three had anuria; urine volume re-
turned to normal rapidly and renal function became
normal within 4 to 5 days.
DR. C. VAN YPERSELE: Your observations are in
agreement with those of many others who have at-
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tributed these signs to an overdose of the drug, thus
characterizing the effect as toxic, which is only part
of the picture. The possible existence, documented
in a few cases, of preformed antibodies should not
be ignored in evaluating the clinical evolution of
AIN. Once the concentration of glafenin is suf-
ficient in the kidney, an interstitial reaction ensues.
DR. G. R0RIvE: I should like to know if you can
classify the drugs involved in AIN according to the
type of immune reaction elicited by each agent.
DR. C. VAN YPERSELE: I do not believe that such
a classification can be made. As a matter of fact,
there is evidence that the same drug may be nephro-
toxic through different mechanisms. For instance,
in methicillin-induced AIN, anti-TBM antibodies
have been present in a few patients. Clearly, anoth-
er mechanism must be invoked in those patients in
whom no anti-TBM antibodies have been demon-
strated. This latter category includes the majority of
patients with methicillin-induced AIN [18]. It is also
possible that one mechanism, such as the develop-
ment of anti-TBM antibodies, is only a secondary
response that amplifies the interstitial lesions in-
duced by another primary reaction.
DR. J. T. HARRINGTON: Dr. McCluskey has
stated that in 10 patients with drug-induced allergic
interstitial nephritis they were unable to find circu-
lating anti-TBM antibodies in any patients, yet all
had similar histologic findings and clinical histories
[88]. That observation would relegate anti-TBM
antibodies to secondary importance.
DR. Y. PIRSON (Physician, Renal Service, Clini-
ques Universitaires St-Luc, Louvain en Woluwe,
Brussels): Dr. Masson, what is the specificity of the
different types of immunologic tests that have been
mentioned in identifying humoral and cellular im-
mune reactions and delayed hypersensitivity?
DR. P. MASSON (Professor of Experimental Medi-
cine, University of Louvain Medical School, Lou-
vain en Woluwe, Brussels): It is impossible, in fact,
to get an immune reaction if there is no lymphoblas-
tic transformation. Each time an immune response
occurs there is a lymphoblastic transformation.
Thus, it is impossible on the basis of this test to say
whether the immune response is either humoral or
cellular. When the antibody is detected in the
blood, then of course it is a humoral response, but
on the basis of just a lymphoblastic transformation I
would not dare to say that it was just a cellular one.
The lymphocyte incorporation of thymidine, which
is used in this test, will be due not only to T lympho-
cytes but also to the B lymphocytes and other cells
that could be involved. So I would be very careful
in interpreting it.
DR. G. R0RIvE: Would you say the reverse?
Would you say that if you have lymphoblastic trans-
formation, this means that the drug could produce
such an effect?
DR. P. MASSON: That means that the body is
mounting an immune response against this drug, but
it doesn't mean that the mechanism is necessarily
involved in the pathogenesis of the disease.
DR. N. LAMEIRE: Patients with AIN often take
one or more drugs. In one case we have seen, the
patient took approximately 20 drugs. In such a pa-
tient, it is difficult to determine whether the reaction
is drug related and which drug is responsible.
Couldn't you then perform a lymphoblastic trans-
formation test in which all 20 drugs would be tested,
eliminate some of them, and conclude that one or
another drug may be responsible?
DR. P. MASSON: Statistically, you increase your
chances. If you have a lymphoblastic transforma-
tion with a given drug, of course you have more
chance that this drug is involved. I would ask a
question myself. Is AIN very often associated with
other disorders? You mentioned a positive Coombs
test. What I mean is, for example, is there hemolysis
or thrombocytopenic purpura, or is the disorder re-
stricted to the kidney?
DR. C. VAN YPERSELE: Hemolytic anemia has
been occasionally reported, for instance in associa-
tion with glafenin-induced AIN.
DR. G. R0RIvE: Perhaps the most usual hemato-
logic disorder is eosinophilia. Isn't it?
DR. C. VAN YPERSELE: Yes. If I may go back to
the question which was put to Dr. Masson. You
said that the lymphoblastic transformation test
merely shows that some immune stimulation has
occurred. Whether it reacts in the kidney or not is
another matter. What is your feeling on the specific-
ity of the leukocyte migration inhibition test?
DR. P. MASSON: Exactly the same. The specifici-
ty is certainly not better than the lymphoblastic
transformation test and personally I would trust the
lymphoblastic transformation more than the so-
called MIF test, which is measuring the migration
inhibiting factor.
DR. C. VAN YPERSELE: Why?
DR. P. MASSON: Oh, just for technical reasons;
the lymphoblastic transformation test is easier to
perform. Personally, I would recommend obtaining
an intradermal reaction as soon as you suspect a
drug; a simple scratch test or an intradermal injec-
tion of a small amount of this could be useful and
perhaps be more informative than all of these so-
phisticated tests, which are somewhat fashionable.
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I think that sometimes a skin test can give as much
information as a laboratory test.
Reprint requests to Dr. C. van Ypersele de Strihou, Université
Catholique de Louvain, Bruxelles, Belgique.
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